Tìm kiếm
Treatment
The range of medical, psychological, and social services designed to help individuals reduce or stop substance use and manage substance use disorders. Treatment may include assessment, counselling and behavioural therapies, medication-assisted treatment, withdrawal management, and support for co-occurring mental or physical health conditions. Effective treatment is typically person-centred and evidence-informed, and may be provided in outpatient, community, or residential settings. Treatment aims to improve health and functioning, reduce substance-related harms, and support individuals in moving toward recovery and long-term wellbeing.
New Resource: Time to Act!
Time to Act! outlines pragmatic and concrete actions, following the UN General Assembly Special Session 2016 (UNGASS 2016), for prevention of non-medical use of controlled substances, treatment of drug use disorders, social protection and...
Standards for Opioid Use Disorder Care: An Assessment of Nordic Approaches
Opioid Use disorder is one of the most challenging forms of addiction facing health care systems around the world. The treatment of opioid dependence is important to reduce its health and social consequences and to improve the well-being...
The Link between the Marketing of Opioid Products with Mortality from Opioid-Related Overdoses
Prescription opioids are involved in 40% of all deaths from opioid overdose in the United States and are often the first opioids encountered by individuals with opioid use disorder.
Alcohol Treatment in Ireland 2011 to 2017
The Health Resource Board has published its latest bulletin and infographic describing the trends in treated problem alcohol use between 2011 to 2017.
Effectiveness Bank Analysis: Make Patients Partners in Therapy
Research findings amalgamated for the American Psychological Association show that outcomes of psychosocial treatments are substantially improved when clients and therapists agree on goals and methods and form collaborative relationships...
Marco técnico de acción para orientar las acciones de reducción del consumo de drogas en el Sistema Penitenciario y Carcelario
El documento de marco técnico de acción para orientar las acciones de reducción del consumo de drogas en el Sistema Penitenciario y Carcelario fue elaborado con la asesoría de la Corporación Viviendo, en el marco del Proyecto “Apoyo...
Families First
Alcohol and Families Alliance believe current policy does not sufficiently protect family members. The aim of AHA is to reduce the harms experienced by children and families affected by alcohol use.
Alcohol Consumption and Parenthood
A recent study sought to determine the extent to which the transition to parenthood protects against problematic alcohol consumption.
E-Collection: Alcohol Consumption and Harmful Use of Alcohol
E-collection, put together by the European Journal of Public Health, analysing alcohol consumption and related harm.
Webinar: Compassionate Pragmatism an Integrative Approach to Treating Problematic Substance Use
Andrew Tatarsky, Ph.D., Founder and Director The Center for Optimal Living will take us through a harm reduction approach which has compassion at its centre. This webinar looks at harm reduction across the range of risk behaviours...
The Substance Use Intervention Team: A Preliminary Analysis of a Population-level Strategy to Address the Opioid Crisis at an Academic Health Center
Objective: In 2017, an academic health center in Chicago launched the multidisciplinary Substance Use Intervention Team (SUIT) to address opioid misuse across 18 inpatient units and in a new outpatient addiction medicine clinic. This report...
Prevalence of Undiagnosed PTSD among In-Patients in an SUD Treatment Centre
Post traumatic stress disorder (PTSD) is a common co-ocuring disorder among patients with substance use disorders. Treatment of PTSD improves SUD treatment outcome. Many studies show that a large number of patients with co-morbid PTSD do...
Psychoactive Substance Dependence in Females: A Three Year Review
Psychoactive substance use was regarded as a male affair in the past. However, recent findings show an increasing number of females are getting involved. We conducted a three year retrospective review of patients admitted to the Centre for...
Inside Health Podcast- E-cigarettes, Prehabilitation before surgery, Hospital safety
This Inside Health podcast discusses why vaping is dividing public health experts causing a polarised split; prehabilitation before cancer surgery and the benefits of preparing for an operation; plus can hospital safety be compared to...
Training Workshop on "Screening, Brief Intervention and Referral for Treatment"
The objective of this two day training workshop "Screening, Brief Intervention, and Referral to Treatment (SBIRT)" was to train mental health professionals so that they could identify substance use problems, help their clients if they are...
A Cross-Journal Call for Papers- Substance Use, Misuse and Dependence: Prevention and Treatment
Substance use and misuse affect people worldwide, of all ages and from all walks of life, resulting in a substantial burden of ill health and mortality, and presenting big challenges in prevention and treatment.
PLOS Medicine is planning...
Relevancia clínica de los receptores GABA-b en el tratamiento de la adicción a las drogas
Resumen
El ácido γ-aminobutírico (GABA) es el principal neurotransmisor inhibitorio del sistema nervioso central (SNC) de los mamíferos y ejerce su acción a partir de la activación de tres receptores distintos. El receptor GABAB es una...
The Effects of Oxytocin on Withdrawal, Craving and Stress Response in Heroin-Dependent Patients
According to the World Drug Report opioids are the most harmful drug type, accounting for 70% of the adverse health impacts associated with drug use disorders worldwide. Treatment typically focusses on controlling withdrawal, preventing...
United Nations Toolkit on Synthetic Drugs
The UN Synthetic Drugs Toolkit is a group of electronic resources carefully put together by organisations such as UNODC, WHO and INCB.
The International Guidelines on Human Rights and Drug Policy
The International Guidelines on Human Rights and Drug Policy, developed by WHO UNAids UNDP and the International Centre for Human Rights Policy, are a reference tool for policy-makers, lawyers and civil society organisations working to ensure human rights compliance in drug policy.
